Curran et al developed a score for patients with pleural mesothelioma based on survival of patients in the European Organization for Research and Treatment of Cancer (EORTC) Clinical Trials. This can be used to separate patients into good and poor prognostic groups. The authors are from the EORTC Data Center in Brussels and universities in Belgium and the Netherlands.